Piramal Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 1,729.31 | 1,273.02 | 1,390.77 |
| Operating Expense | 1,273.22 | 1,028.98 | 1,031.50 |
| Net Profit | 277.27 | 118.80 | 210.06 |
| Net Profit Margin | 16.03 | 9.33 | 15.10 |
| Earning Per Share | 2.09 | 0.90 | 1.59 |
| EBIDTA | 438.55 | 244.26 | 355.25 |
| Effective Tax Rate | 15.25 | 16.73 | 17.15 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 1729.31 |
| Operating Expense | 1273.22 |
| Net Profit | 277.27 |
| Net Profit Margin | 16.03 |
| Earning Per Share | 2.09 |
| EBIDTA | 438.55 |
| Effective Tax Rate | 15.25 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 5,285.71 | 4,390.11 | 3,443.22 |
| Operating Expenses Annual | 4,245.27 | 3,772.19 | 3,345.69 |
| Operating Profit Annual | 1,247.79 | 819.98 | 431.64 |
| Interest Annual | 114.56 | 107.10 | 115.87 |
| Depreciation | 222.09 | 205.26 | 192.08 |
| Net Profit Annual | 691.40 | 391.22 | 69.50 |
| Tax Annual | 219.74 | 116.40 | 54.19 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 5,285.71 |
| Operating Expenses Annual | 4,245.27 |
| Operating Profit Annual | 1,247.79 |
| Interest Annual | 114.56 |
| Depreciation | 222.09 |
| Net Profit Annual | 691.40 |
| Tax Annual | 219.74 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 228.80 | 54.28 | 127.69 |
| Cash Flow from Operations | 548.77 | 358.29 | 71.52 |
| Cash Flow from Investing | -551.96 | -635.15 | -435.05 |
| Cash Flow from Financing | -61.74 | 451.38 | 290.12 |
| Cash Flow at the End | 163.87 | 228.80 | 54.28 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 228.80 |
| Cash Flow from Operations | 548.77 |
| Cash Flow from Investing | -551.96 |
| Cash Flow from Financing | -61.74 |
| Cash Flow at the End | 163.87 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 23.61 | 18.68 | 12.54 |
| PBIT Margin (%) | 19.41 | 14 | 6.96 |
| PBT Margin (%) | 19.24 | 13.87 | 6.90 |
| Net PROFIT Margin (%) | 13.08 | 8.91 | 2.02 |
| Return On Networth / Equity (%) | 9.76 | 6.53 | 1.34 |
| Return On Networth /Employed (%) | 12.31 | 8.27 | 3.62 |
| Return On Assets (%) | 8.24 | 5.26 | 1.05 |
| Total Debt / Equity (X) | 0.17 | 0.24 | 0.27 |
| Asset Turnover Ratio (%) | 0.63 | 0.59 | 0.52 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 23.61 |
| PBIT Margin (%) | 19.41 |
| PBT Margin (%) | 19.24 |
| Net PROFIT Margin (%) | 13.08 |
| Return On Networth / Equity (%) | 9.76 |
| Return On Networth /Employed (%) | 12.31 |
| Return On Assets (%) | 8.24 |
| Total Debt / Equity (X) | 0.17 |
| Asset Turnover Ratio (%) | 0.63 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 3,143.90 | 2,913 | 2,881.94 |
| Total Current Assets Annual | 3,535.88 | 3,291.55 | 2,348.68 |
| Non Current Assets Annual | 6,855.95 | 6,259.33 | 5,693.72 |
| Total Shareholders Funds Annual | 7,452.54 | 6,712.07 | 5,261.79 |
| Total Assets Annual | 10,391.83 | 9,550.88 | 8,042.40 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 3,143.90 |
| Total Current Assets Annual | 3,535.88 |
| Non Current Assets Annual | 6,855.95 |
| Total Shareholders Funds Annual | 7,452.54 |
| Total Assets Annual | 10,391.83 |
EPS (INR)
Expected
1.16
Reported
1.16
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
